Dave, N., Gier, S., Kessler, M., Rodriguez, M., Barta, S., Chong, E., Cohen, A., Frey, N., Gill, S., Heck, S., Hexner, E., Hossain, N., Kapur, S., Landsburg, D., Loren, A., Luger, S., Martin, M. E., Munshi, P., Nasta, S. D., Perl, A., Porter, D., Schuster, S., Stadtmauer, E., Susanibar-Adaniya, S., Svoboda, J., Togliatii, A., Vogl, D., Waxman, A., Wu, D., McCurdy, S. (2025). Fried's frailty phenotype predicts survival in pts with relapsed/refractory lymphoma or myeloma undergoing chimeric antigen receptor T-cell therapy – a prospective, observational Study. Blood. https://doi.org/10.1182/blood-2025-7189